Gestodene-Loaded Dissolving Microneedles
GEST-Loaded DMNs
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Intradermal
-
Intended Duration:
- Short-Acting
- Development Stage: Discovery & Early Development
- Developer(s)/researcher(s): China National Research Institute for Family Planning, Chinese Academy of Sciences
Details
- API: Gestodene
- Target: Progesterone Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Cervical Mucus Changes
- Endometrial Changes
- Inactive Materials: Polyvinylpyrrolidone
- MPT: Not Potential MPT
- Promising Attributes: Microarray patches are a promising delivery option, with potential for more controlled drug release and pain-free, user controlled dosing.
Product Status
Active Early Development Research
History
In 2023, studies were completed to fabricate GEST microneedles and investigate in vivo pharmacokinetics and characteristics.